President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...
The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug ...
Applied Therapeutics (APLT) announced the FDA has issued a Complete Response Letter for the New Drug Application for govorestat, for ...
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
(In Nov. 22 story, corrects list price of Pfizer's drug to about $268,000 from $225,000 in paragraph 3) (Reuters) -The U.S.
The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana ...
In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...